| 
				Breen, who is currently the chairman of DuPont, will replace 
				Marc Doyle, the company said on Tuesday.
 The board concluded now is the right time to restore Breen to 
				the chief executive role to draw more directly on his 
				substantial operating experience, DuPont's lead independent 
				director Alexander Cutler said in a statement.
 
 DuPont last month reported fourth-quarter profit below estimates 
				as it struggled with subdued demand in the electronics and 
				automotive sectors, largely due to the U.S.-China trade war.
 
 "While we made some progress in 2019, we did not meet our own 
				expectations and we now need to move aggressively to secure our 
				foundation for growth," Breen said in a statement.
 
 Breen recently orchestrated the divestiture of DuPont's $26 
				billion nutrition unit in a merger with International Flavors & 
				Fragrances Inc <IFF.N>, less than a year after spearheading the 
				breakup of DowDuPont into three companies.
 
 DuPont also named Lori Koch as chief financial officer, 
				replacing Jeanmarie Desmond, and said it will advance the 
				cost-cutting initiatives announced earlier.
 
 The executive changes are effective immediately and both Doyle 
				and Desmond will leave the company, DuPont said.
 
 (Reporting by Shariq Khan and Taru Jain in Bengaluru; Editing by 
				Sriraj Kalluvila)
 
			[© 2020 Thomson Reuters. All rights 
				reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
				 
				  |  |